drugset
drugset / Trial / NCT04391582

Pediatric Burn Treatment Using Tilapia Skin as a Xenograft for Superficial-Partial Thickness Wounds

NCT04391582 ↗

Phase 2 Completed 30 enrolled Drug Research and Development Center, Federal University of Ceara
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to evaluate the efficacy of Nile tilapia skin as a xenograft for the treatment of partial-thickness burn wounds in children.

Timeline

Start
2017-05-01
Primary completion
2018-04-12
Completion
2018-04-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Silver Sulfadiazine Small molecule 1 % Topical

Indications

No indication recorded.